Reviva Pharmaceuticals Holdings RVPH
OTC RVPH
$0.34 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Reviva Pharmaceuticals Holdings (RVPH) Accounts Payables (2018 - 2026)

Updated

Reviva Pharmaceuticals Holdings (RVPH) reported Accounts Payables of $2.46 million for Q2 2026, down 50.6% from $4.97 million a year earlier but up 17.8% from the prior quarter.

Analysis

Reviva Pharmaceuticals Holdings (RVPH) Accounts Payables (2018 - 2026) Analysis & Trends

At the end of FY2025, Reviva Pharmaceuticals Holdings posted Accounts Payables of $3.01 million, down 52.1% from FY2024.

  • Accounts Payables has a five-year compound annual growth rate of 24.4% (FY2020 to FY2025).
  • By year, Accounts Payables came in at $6.28 million in FY2024 (+63.2%), $3.85 million in FY2023 (+9.3%) and $3.52 million in FY2022.
  • Five-year quarterly Accounts Payables spans a low of $420,783 in Q3 2021 and a high of $8.78 million in Q3 2024.
  • Year over year, Accounts Payables has now declined in each of the last four quarters, with an average decline of 9.8% over the last eight quarters.
  • The high point for year-over-year Accounts Payables in five years was Q2 2022 (growth of 612.7%); the low point was Q1 2026 (a decline of 55.8%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $2.09 million (Q1 2026), $3.01 million (Q4 2025) and $5.43 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 5.79 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 9.32 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 34.43 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 5.03 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -23.57 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 2.95 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 934.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 4.07 Bn
10 Reviva Pharmaceuticals Holdings 4.46 Mn -82.75 Mn - 2.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 2.48 Mn
Jun 30, 2026 2.46 Mn
Mar 31, 2026 2.09 Mn
Dec 31, 2025 3.01 Mn
Sep 30, 2025 5.43 Mn
Jun 30, 2025 4.97 Mn
Mar 31, 2025 4.72 Mn
Dec 31, 2024 6.28 Mn
Sep 30, 2024 8.78 Mn
Jun 30, 2024 4.69 Mn
Mar 31, 2024 5.72 Mn
Dec 31, 2023 3.85 Mn
Sep 30, 2023 5.28 Mn
Jun 30, 2023 2.65 Mn
Mar 31, 2023 2.86 Mn
Dec 31, 2022 3.52 Mn
Sep 30, 2022 2.35 Mn
Jun 30, 2022 2.55 Mn
Mar 31, 2022 1.43 Mn
Dec 31, 2021 509,583.00
API Access

Reviva Pharmaceuticals Holdings Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=RVPH&period=max&api_key=YOUR_API_KEY